PPARG and cancer: Overall, targeting hypoxia-induced angiogenesis by PPAR-γ ligands may prove to be a promising therapyfor the treatment of cancer; however, the precise mechanisms involved inhypoxia-induced angiogenesis process remain to be clarified.